Morristown, NJ—OmniActive Health Technologies has entered into an exclusive distribution partnership in China with Shanghai Prochin, according to a press release. Shanghai Prochin will market Lutemax 2020 Lutein and Zeaxanthin Isomers to the nutraceutical industry in China.
The release notes that the global nutrition supplement market is expected to reach $220.3 billion by 2022, with China expected to reach $40 billion by 2023, growing at a CAGR of 14%. China may soon become the most significant nutritional supplement market in the world.
Related: OmniActive Named Best Nutraceutical Company at World Quality Congress
Aker BioMarine Enters Partnership with Acasti Pharma
BASF Strengthens Biotech Footprint, Enters Natural Flavors & Fragrances Market
Johan Kamphuis, President, Global Business, at OmniActive, said in the release: “China’s 1.4 billion people account for the highest general population on the globe, and with screen time on the rise as well as an increase in life expectancy and changes in diet, the clinically studied, globally recognized vision and cognitive health and performance benefits of Lutemax 2020 will fill a much needed nutritional gap. We stand confident that combining Shanghai Prochin’s capabilities and OmniActive’s expertise in innovation and technologies will ensure sustainable growth in this key market.”